InvestSMART

Austco Healthcare Limited (ASX: AHC) - Announcements

- Current share price for AHC : $0.230

ASX company news and announcements for Austco Healthcare Limited (AHC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Austco Healthcare Limited (AHC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Austco Healthcare Limited (AHC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Austco Healthcare Limited (AHC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$86 Change of Director's Interest Notice - Billings 6 Sep 2021 9:01AM $0.150 $0.230 risen by 53.33%
$86 Change of Director's Interest Notice - Burns 3 Sep 2021 10:57AM $0.150 $0.230 risen by 53.33%
$86 Appendix 4G and Corporate Governance Statement 27 Aug 2021 10:19AM $0.150 $0.230 risen by 53.33%
$86 Austco FY21 Results Release 27 Aug 2021 10:18AM $0.150 $0.230 risen by 53.33%
$86 Appendix 4E & FY21 Financial Statements 27 Aug 2021 10:17AM $0.150 $0.230 risen by 53.33%
$86 Austco Healthcare wins AUD $3.3M contract 5 Jul 2021 12:18PM $0.120 $0.230 risen by 91.67%
$86 Response to ASX Price Query 10 Jun 2021 1:59PM $0.125 $0.230 risen by 84%
$86 Austco Healthcare expects improved profit for FY21 28 May 2021 9:01AM $0.096 $0.230 risen by 139.58%
$86 Change of Director's Interest Notice - Burns 5 Mar 2021 2:28PM $0.095 $0.230 risen by 142.11%
$86 Austco Healthcare Investor Presentation 4 Mar 2021 8:54AM $0.090 $0.230 risen by 155.56%
$86 Austco Healthcare HY21 Results and Media Release 26 Feb 2021 11:32AM $0.097 $0.230 risen by 137.11%
$86 Austco Healthcare Appendix 4D and Interim Financial Report 26 Feb 2021 11:27AM $0.097 $0.230 risen by 137.11%
$86 Receipt of funds from settlement of litigation 18 Dec 2020 8:24AM $0.105 $0.230 risen by 119.05%
$86 Austco Singapore wins $1.3m new contract 14 Dec 2020 12:53PM $0.092 $0.230 risen by 150%
$86 Suspension from Official Quotation at Close of Business 13 Dec 2013 2:22PM $2.100 $0.230 fallen by 89.05%
$86 Letter to Shareholders 26 Sep 2013 4:01PM $2.100 $0.230 fallen by 89.05%
$86 Preliminary Final Report 28 Aug 2013 1:10PM $2.100 $0.230 fallen by 89.05%
$86 Changes relating to buy-back - Appendix 3D 5 Mar 2013 9:59AM $2.100 $0.230 fallen by 89.05%
$86 Half Yearly Report and Accounts 26 Feb 2013 11:03AM $2.100 $0.230 fallen by 89.05%
$86 Half Year Results 22 Feb 2013 11:49AM $2.100 $0.230 fallen by 89.05%
$86 Interim Dividend 5 Dec 2012 1:36PM $2.020 $0.230 fallen by 88.61%
$86 Sale of Head Office Building 16 Nov 2012 4:54PM $2.050 $0.230 fallen by 88.78%
$86 Preliminary Final Report 29 Aug 2012 2:40PM $2.050 $0.230 fallen by 88.78%
$86 Market Release Unaudited June 12 Operating results 22 Aug 2012 12:52PM $2.050 $0.230 fallen by 88.78%
$86 Changes relating to buy-back - Appendix 3D 2 Mar 2012 2:51PM $2.200 $0.230 fallen by 89.55%

201 - 225 of 289 results

Page 9 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.